The Integrative Medicine for Pain Management in Oncology Guidelines, jointly published in 2022 by the Society for Integrative Oncology (SIO) and ASCO, aims to provide evidence-based recommendations to practicing physicians and other health care providers on integrative approaches for pain management in patients with cancer. As per the Guidelines, this five module series discusses considerations required to make informed decisions on recommended integrative approaches for five pain management scenarios as listed below. The introductory module goes into the methodology used for the guidelines.
AROMATASE INHIBITOR-RELATED JOINT PAIN
GENERAL CANCER PAIN OR MUSCULOSKELETAL PAIN